Form 4: BiomX Inc. Executive Assaf Oron Reports Acquisition of 25,804 Common Stock Units
SEC Form 4 Filing
Chief Business Officer of BiomX Inc., Assaf Oron, reports the acquisition of 25,804 Restricted Stock Units (RSUs) that convert into common stock.
Summary
- On September 16, 2024, Assaf Oron, Chief Business Officer of BiomX Inc., filed a Form 4.
- The form reports the acquisition of 25,804 Restricted Stock Units (RSUs).
- These RSUs are immediately vested and convert into BiomX Inc.'s common stock on a one-for-one basis.
- The transaction was reported on September 18, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to executive compensation, indicating a neutral sentiment.
Positives
- The acquisition of RSUs by a key executive could be seen as a positive sign of confidence in the company's future.
Industry Context
This filing is a routine disclosure related to executive compensation and is common in the biotechnology industry.
Stakeholder Impact
- The acquisition of RSUs by a key executive may have a minor positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 09/16/2024 | Date of transaction: acquisition of 25,804 Restricted Stock Units |
| 09/18/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.